The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Air travelers faced delays at U.S. airports on Friday afternoon after a computer issue snarled processing of international arrivals.Airlinesread more
COPENHAGEN, April 5 (Reuters) - Novozymes has signed up two new partners for its biological agriculture business (BioAg), adding to its previously exclusive partnership with German chemicals giant Bayer in a drive to boost growth.
The Danish company is the world's largest maker of industrial enzymes and with BioAg produces microbes such as bacteria and fungi to protect plants from pests and help them to grow faster.
It will continue a close innovation and commercial partnership with Bayer within corn and soy, Novozymes said late on Thursday, as it presented two new partners - Univar Solutions and UPL.
The Danish firm's shares were up 2.7 percent at 0910 GMT.
Novozymes said it had been happy with its collaboration since 2014 with Monsanto and then Bayer, which bought Monsanto last year for $63 billion.
"But there are of course things they don't have focus on, for example peanuts. That's one area we can now send to a place where it will get the needed attention," head of Novozymes' Agriculture & Bioenergy business Tina Sejersgaard Fano said.
She said the decision was not linked to last week's ruling from a U.S. jury to award $80 million to a man who claimed use of Bayer's weed killer Roundup caused his cancer, or the thousands of potential similar looming lawsuits.
"Of course we follow the court case, but is has nothing to do with our decision. We're working with Bayer on making agriculture more sustainable by making solutions that gives a better yield with fewer chemicals," Fano said.
Novozymes' BioAg business is a part of its Agriculture and Feed division, which accounted for 14 percent of its total sales of 14.4 billion Danish crowns ($2.17 billion) last year.
($1 = 6.6493 Danish crowns) (Reporting by Teis Jensen; Editing by Mark Potter)